New radiation combo aims to extend life for patients with up to 10 tumors
NCT ID NCT05717166
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tests whether adding a precise, high-dose radiation treatment called SABR to standard care can improve survival in people with a primary tumor and up to 10 additional tumors that have spread. About 180 adults with various cancer types will be randomly assigned to standard care alone or standard care plus SABR. The main goal is to see if the combination helps patients live longer, with secondary focus on quality of life and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer - Centre for the North
NOT_YET_RECRUITINGPrince George, British Columbia, V2M 7E9, Canada
Contact
-
BC Cancer - Vancouver
RECRUITINGVancouver, British Columbia, V5Z 4C2, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier de l'Université de Montréal-CHUM
RECRUITINGMontreal, Quebec, H2X 0C1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
London Regional Cancer Program of the Lawson Health Research Institute
RECRUITINGLondon, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Universitätsspital Zürich
RECRUITINGZurich, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.